Global Health Limited has informed the Exchange about Schedule of meet
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Global Health Limited (Medanta) has announced a schedule of meetings with analysts and institutional investors between September 4 and September 17, 2025. The lineup includes a one-to-one with Aditya Birla Capital on September 4, a UBS-organized group meeting on September 10, Citi India Healthcare and Pharma Tour plus a Jefferies group meeting on September 15, and the Jefferies 4th India Forum on September 17. All meetings are planned in physical mode at Gurugram. The company clarified that no unpublished price-sensitive information (UPSI) will be shared during these interactions, and the schedule is subject to change due to unforeseen circumstances.
This is a routine regulatory disclosure showing active institutional engagement. Participation by major global brokerages like UBS, Citi, and Jefferies indicates continued institutional interest in Medanta, but since no new information is being shared, the meetings are unlikely to trigger any immediate stock price reaction.